Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Reviews Disease Primers. 2021;7(1):86.

Article  PubMed  Google Scholar 

Tansley SL, McHugh NJ, Wedderburn LR. Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? Arthritis Res Therapy. 2013;15(2):211.

Article  Google Scholar 

DeWane ME, Waldman R, Lu J, Dermatomyositis. Clinical features and pathogenesis. J Am Acad Dermatol. 2020;82(2):267–81.

Neely J, Rychkov D, Paranjpe M, Waterfield M, Kim S, Sirota M. Gene expression Meta-analysis reveals concordance in Gene activation, pathway, and Cell-Type Enrichment in Dermatomyositis Target tissues. ACR Open Rheumatol. 2019;1(10):657–66.

Article  PubMed  PubMed Central  Google Scholar 

Stenzel W, Goebel H-H, Bader-Meunier B, Gitiaux C. Inflammatory myopathies in childhood. Neuromuscul Disord. 2021;31(10):1051–61.

Article  PubMed  Google Scholar 

Pinal-Fernandez I, Casal-Dominguez M, Derfoul A, Pak K, Plotz P, Miller FW, et al. Identification of distinctive interferon gene signatures in different types of myositis. Neurology. 2019;93(12):e1193–204.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moneta GM, Pires Marafon D, Marasco E, Rosina S, Verardo M, Fiorillo C, et al. Muscle expression of type I and type II interferons is increased in Juvenile Dermatomyositis and related to clinical and histologic features. Arthritis Rheumatol. 2019;71(6):1011–21.

Article  CAS  PubMed  Google Scholar 

Tabata MM, Hodgkinson LM, Wu TT, Li S, Huard C, Zhao S, et al. The type I Interferon signature reflects multiple phenotypic and activity measures in Dermatomyositis. Arthritis Rheumatol. 2023;75(10):1842–9.

Article  CAS  PubMed  Google Scholar 

Seto N, Torres-Ruiz JJ, Carmona-Rivera C, Pinal-Fernandez I, Pak K, Purmalek MM, et al. Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies. JCI Insight. 2020;5(3):e134189.

Article  PubMed  PubMed Central  Google Scholar 

Duvvuri B, Pachman LM, Morgan G, Khojah AM, Klein-Gitelman M, Curran ML, et al. Neutrophil Extracellular traps in tissue and periphery in Juvenile Dermatomyositis. Arthritis Rheumatol. 2020;72(2):348–58.

Article  CAS  PubMed  Google Scholar 

Ward JM, Ambatipudi M, O’Hanlon TP, Smith MA, de Los Reyes M, Schiffenbauer A, et al. Shared and Distinctive Transcriptomic and Proteomic pathways in Adult and Juvenile Dermatomyositis. Arthritis Rheumatol. 2023;75(11):2014–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reed AM, Peterson E, Bilgic H, Ytterberg SR, Amin S, Hein MS, et al. Changes in novel biomarkers of disease activity in juvenile and adult dermatomyositis are sensitive biomarkers of disease course. Arthr Rhuem. 2012;64(12):4078–86.

Article  CAS  Google Scholar 

Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatr. 2006;148(2):247–53.

Article  PubMed  Google Scholar 

Wienke J, Pachman LM, Morgan GA, Yeo JG, Amoruso MC, Hans V, et al. Endothelial and inflammation biomarker profiles at diagnosis reflecting clinical heterogeneity and serving as a Prognostic Tool for Treatment Response in two independent cohorts of patients with Juvenile Dermatomyositis. Arthritis Rheumatol. 2020;72(7):1214–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Annals Rheumtic Dis. 2017;76(12):1955–64.

Article  Google Scholar 

Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology. 2001;40(11):1262–73.

Article  CAS  PubMed  Google Scholar 

Ruperto N, Ravelli A, Pistorio A, Ferriani V, Calvo I, Ganser G, et al. The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/european League against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation study. Arthritis Care Res. 2008;59(1):4–13.

Article  Google Scholar 

Yeker RM, Pinal-Fernandez I, Kishi T, Pak K, Targoff IN, Miller FW, et al. Anti-NT5C1A autoantibodies are associated with more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2018;77(5):714.

Article  CAS  PubMed  Google Scholar 

Sabbagh S, Pinal-Fernandez I, Kishi T, Targoff IN, Miller FW, Rider LG, Mammen AL. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis. Ann Rheum Dis. 2019;78(7):988.

Article  PubMed  Google Scholar 

Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM et al. The clinical phenotypes of the Juvenile Idiopathic Inflammatory myopathies. Medicine. 2013;92(1).

Kishi T, Rider LG, Pak K, Barillas-Arias L, Henrickson M, McCarthy PL, et al. Association of Anti–3-Hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with DRB1*07:01 and severe myositis in Juvenile Myositis patients. Arthritis Care Res. 2017;69(7):1088–94.

Article  CAS  Google Scholar 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.

Article  PubMed  PubMed Central  Google Scholar 

Benjamini Y, Hochberg Y. Controlling the false Discovery rate: a practical and powerful Approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289–300.

Article  Google Scholar 

Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847–9.

Article  CAS  PubMed  Google Scholar 

Rusinova I, Forster S, Yu S, Kannan A, Masse M, Cumming H, et al. INTERFEROME v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013;41(D1):D1040–6.

Article  CAS  PubMed  Google Scholar 

Krämer A, Green J, Pollard J Jr., Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics. 2014;30(4):523–30.

Article  PubMed  Google Scholar 

Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and Patient/Parent global activity, manual muscle testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity score (DAS), short form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), Myositis Functional Index-2 (FI-2), Myositis activities Profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), cutaneous Assessment Tool (CAT), Dermatomyositis skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Volume 63. Arthritis Care & Research; 2011. pp. S118–57. 0 11.

Arshanapalli A, Shah M, Veerula V, Somani A-K. The role of type I interferons and other cytokines in dermatomyositis. Cytokine. 2015;73(2):319–25.

Article  CAS  PubMed  Google Scholar 

Tawalbeh SM, Marin W, Morgan GA, Dang UJ, Hathout Y, Pachman LM. Serum protein biomarkers for juvenile dermatomyositis: a pilot study. BMC Rheumatol. 2020;4(1):52.

Article  PubMed  PubMed Central  Google Scholar 

Collison J. Serum biomarkers of disease activity in JDM. Nat Rev Rheumatol. 2019;15(5):250.

PubMed  Google Scholar 

Turnier JL, Pachman LM, Lowe L, Tsoi LC, Elhaj S, Menon R, et al. Comparison of Lesional Juvenile Myositis and Lupus skin reveals overlapping yet Unique Disease Pathophysiology. Arthritis Rheumatol. 2021;73(6):1062–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Quan C, Diao L, Xue F, Xue K, Wang B, et al. Measurement of cytokines and chemokines and association with clinical severity of dermatomyositis and clinically amyopathic dermatomyositis. Br J Dermatol. 2018;179(6):1334–41.

Article  CAS  PubMed  Google Scholar 

De Paepe B, Verhamme F, De Bleecker JL. The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis. Cytokine. 2020;127:154966.

Article  PubMed  Google Scholar 

Komiya T, Negoro N, Kondo K, Miura K, Hirota Y, Yoshikawa J. Clinical significance of Von Willebrand factor in patients with adult dermatomyositis. Clin Rheumatol. 2005;24(4):352–7.

Article  PubMed